Jula K. Inrig

Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes

Lynda A. Szczech, Huiman X. Barnhart, Jula K. Inrig et al. · Kidney International · 2008 · 522 citations · Full text

Medicine, Hematology, Pharmacology +9

Use of Vancomycin or First-Generation Cephalosporins for the Treatment of Hemodialysis-Dependent Patients with Methicillin-Susceptible Staphylococcus aureus Bacteremia

Martín E. Stryjewski, Lynda A. Szczech, Danny Benjamin et al. · Clinical Infectious Diseases · 2006 · 346 citations · Full text

Medicine, Nephrology, Pharmacotherapy +16

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 215 citations · Full text

Medicine, Internal Medicine, Nephrology +12

Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients

Jula K. Inrig, E.Z. Oddone, Vic Hasselblad et al. · Kidney International · 2007 · 212 citations

Medicine, Internal Medicine, Nephrology +13

Association of Blood Pressure Increases During Hemodialysis With 2-Year Mortality in Incident Hemodialysis Patients: A Secondary Analysis of the Dialysis Morbidity and Mortality Wave 2 Study

Jula K. Inrig, Uptal D. Patel, Robert D. Toto et al. · American Journal of Kidney Diseases · 2009 · 195 citations · Full text

Medicine, Nephrology, Dialysis +15